Is this you? Create Your Porfile
Avatar

Hg Prentice

Royal Free Hospital

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Hg Prentice is active.

Explore More

Publication

Featured researches published by Hg Prentice.

Haematologica | 2004

Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine

Gareth Gerrard; Em Payne; R Baker; Dt Jones; Michael N. Potter; Hg Prentice; M Ethell; H McCullough; Michael Burgess; Atul Mehta; K Ganeshaguru

Archive | 1996

Interleukin-12 fusion protein

Robert James Anderson; Hg Prentice; Ian Duncan Macdonald

Blood | 2003

Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis.

Dt Jones; Kanagasabai Ganeshaguru; Robert J. Anderson; Trevor R. Jackson; K R Bruckdorfer; Sylvia Y Low; Lars Palmqvist; Hg Prentice; A. V. Hoffbrand; Atul Mehta; Rg Wickremasinghe

Archive | 1999

Aav derived vector

Robert James Anderson; Hg Prentice; Ian Duncan Macdonald

Archive | 1999

Aav-vector production

Robert James Anderson; Hg Prentice; Ian Duncan Macdonald

Blood | 1997

Preliminary results of a phase 2 study on a protein kinase C inhibitor (CGP 41251) in low grade lymphoproliferative disorders.

Atul Mehta; Ae Virchis; Dt Jones; Sm Hart; Rg Wickremasinghe; Hg Prentice; Kl Yong; A Man; K CsermakRenner; K Ganeshaguru

Leukemia , 15 (10) pp. 1527-1533. (2001) | 2001

Oligoclonality: an insight into the biology of acute lymphoblastic leukaemia

I Moreira; M Papaionnou; Fy Mortuza; P Gameiro; Gl Palmisano; S Swanton; Christine J. Harrison; Hg Prentice; Atul Mehta; A. V. Hoffbrand; Letizia Foroni

BLOOD , 96 (Abstr) 82a-. (2000) | 2000

A role for C-ABL tyrosine kinase in p53 upregulation and apoptosis in B-CLL cells exposed to chlorambucil

Ae Virchis; K Ganeshaguru; A. V. Hoffbrand; Atul Mehta; Hg Prentice; Rg Wickremasinghe

In: (Proceedings) 5th International Symposium on Leukemia and Lymphoma. (pp. p. 665). NATURE PUBLISHING GROUP (2003) | 2003

Inhibition of P-gp activity in AML patients treated with zosuquidar trihydrochloride

Gareth Gerrard; G Ganeshaguru; B Payne; R Baker; H McCullough; Dt Jones; Michael N. Potter; Hg Prentice; Michael Burgess; Atul Mehta

In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 557A-557A). AMER SOC HEMATOLOGY (2002) | 2002

A phase 1 study of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) in combination with daunorubicin and cytarabine in adult acute myeloid leukemia.

Em Payne; Gareth Gerrard; K Ganeshaguru; H McCullough; M Ethell; Michael N. Potter; Hg Prentice; Michael Burgess; Atul Mehta

Explore More

Collaboration

Dive into the Hg Prentice's collaboration.

Top Co-Authors
Avatar

Atul Mehta

Royal Free London NHS Foundation Trust

View shared research outputs
Top Co-Authors
Avatar

K Ganeshaguru

Royal Free Hospital

View shared research outputs
Top Co-Authors
Avatar

A. V. Hoffbrand

Royal Free Hospital

View shared research outputs
Top Co-Authors
Avatar

Dt Jones

Royal Free Hospital

View shared research outputs
Top Co-Authors
Avatar

Rg Wickremasinghe

University College London

View shared research outputs
Top Co-Authors
Avatar

Michael N. Potter

The Royal Marsden NHS Foundation Trust

View shared research outputs
Top Co-Authors
Avatar

Gareth Gerrard

Imperial College London

View shared research outputs
Top Co-Authors
Avatar

Ian Duncan Macdonald

Royal Free Hospital

View shared research outputs
Top Co-Authors
Avatar

Robert James Anderson

University of London

View shared research outputs
Top Co-Authors
Avatar

Michael Burgess

Eli Lilly and Company

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge